Design and synthesis of a pyridone-based phosphotyrosine mimetic

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 19, 1998, Pages 2813-2816

  Fu, Jian Min ^a   Castelhano, Arlindo L ^a  

^a Cadus Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDONE DERIVATIVE; TYROSINE DERIVATIVE;

ARTICLE; CATALYSIS; DRUG DESIGN; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; X RAY CRYSTALLOGRAPHY;

DRUG DESIGN; PHOSPHOTYROSINE; PYRIDONES; SRC HOMOLOGY DOMAINS;

EID: 0032491228     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00503-4     Document Type: Article

References (24)

1. 1. Plummer, M. S.; Lunney, E. A.; Para, S. K.; Vara Prasad, J. V. N.; Shahripour, A.; Singh, C. J. S.; Humblet, C.; Fergus, J. H.; Marks, J. S.; Sawyer, T. K. Drug Design and Discovery 1996, 13, 75.
2. 2. Cambier, J. C.; Pleiman, C. M.; Clark, M. R. Annu. Rev. Immunol. 1994, 12, 457.
3. 3. Kimura, T.; Kihara, H.; Bhattacharyya, S.; Sakamoto, H.; Appella, E.; Siraganian, R. P. J. Biol. Chem. 1996, 271, 27962.
4. 4. Plummer, M. S.; Holland, D. R.; Shahripour, A.; Lunney, E. A.; Fergus, J. H.; Marks, J. S.; McConnell, B.; Mueller, W. T.; Sawyer, T. K. J. Med. Chem. 1997, 40, 3719.
5. 5. (a) Domchek, S. M.; Auger, K. R.; Chatterjee, S.; Burke, Jr., T. R.; Shoelson, S. E.; Biochemistry, 1992, 31, 9865.
6. (b) Wange, R. L.; Isakov, N.; Burke, Jr., T. R.; Otaka, A.; Roller, P. P.; Watts, J. D.; Aebersold, R.; Samelson, L. E. J. Biol. Chem. 1995, 270, 944.
7. (c) Wange, R. L.; Isakov, N.; Burke, Jr., T. R.; Otaka, A.; Roller, P. P.; Watts, J. D.; Aebersold, R.; Samelson, L. E. J. Biol. Chem. 1995, 270, 944.
8. (d) Plummer, M. S.; Lunney, E. A.; Para, K. S.; Shahripour, A.; Stankovic, C. J.; Humblet, C.; Fergus, J. H.; Saltiel, A.; Sawyer, T. K. Bioorg. Med. Chem. 1997, 5, 41.
9. (e) Furet, P.; Gay, B.; G-Echeverria, C.; Rahuel, J.; Fretz, H.; Schoepfer, J.; Caravatti, G. J. Med. Chem. 1997, 40, 3551.
10. (f) Revesz, L.; Blum, E.; Manning, U.; Demange, B. J.; Widmer, A.; Zuber, J.-F. Bioorg. Med. Chem. Lett. 1997, 7, 2875.
11. 6. (a) Burke, Jr., T. R.; Smyth, M. S.; Otaka, A.; Nomizu, M.; Roller, P. P.; Wolf, G.; Case, R.; Shoelson, S. E. Biochemistry 1994, 33, 6490.
12. (b) Burke, Jr., Smyth, M. S.; Otaka, A.; Roller, P. P. Tetrahedron Lett. 1993, 34, 4125.
13. 2 has also been attributed to a direct interaction of the fluorines with active site residues and not to lower pKa values, see: Chen, L.; Wu, L.; Otaka, A.; Smith, M. S.; Roller, P. R.; Burke, T. R.; den Hertog, J.; Zhang, Z-Y. Biochem. Biophys. Res. Comm. 1995, 216, 976.
14. 2 has also been attributed to a direct interaction of the fluorines with active site residues and not to lower pKa values, see: Chen, L.; Wu, L.; Otaka, A.; Smith, M. S.; Roller, P. R.; Burke, T. R.; den Hertog, J.; Zhang, Z-Y. Biochem. Biophys. Res. Comm. 1995, 216, 976.
15. A2 were subsequently calculated as 7.1 and 7.7 ± 0.3, respectively, using Advanced Chemistry Development, Inc., prediction software.
16. 8. (a) Waksman, G.; Shoelson, S. E.; Pant, N.; Cowburn, D.; Kuriyan, J. Cell 1993, 72, 779.
17. (b) Eck, M. J.; Shoelson, S. E.; Harrison, S. C. Nature 1993, 362, 87.
18. 9. Kelly, T. R.; Bridger, G. J.; Zhao, C. J. Am. Chem. Soc. 1990, 112, 8024.
19. 10. A similar approach to the synthesis of 4-phosphono(difluoromethyl)-L-phenylalanine and pyridylalanine regioisomers starting from 2-, 3-and 4-bromopyridine and β-iodoalanine have been described, see: (a) Smyth, M. S.; Burke, Jr., T. R. Tetrahedron Lett. 1994, 35, 551
20. (b) Walker, M. A.; Kaplita, K. P.; Chen, T.; King, H. D. Synlett 1997, 169.
21. 11. Jung, M. E.; Starkey, L. S. Tetrahedron, 1995, 53, 8815.
22. th National Medicinal Chemistry Symposium, Ann Arbor Michigan, June 18-22.
23. 13. Szardenings, A. K.; Gordeev, M. F.; Patel, D. V. Tetrahedron Lett. 1996, 37, 3635.
24. ++1).